tradingkey.logo
tradingkey.logo
Search

Cibus Inc

CBUS
Add to Watchlist
1.570USD
-0.015-0.95%
Close 09-11 16:00ET
120.43MMarket Cap
LossP/E TTM

More Details of Cibus Inc Company

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Cibus Inc Profile

Ticker SymbolCBUS
Company nameCibus Inc
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)
Number of employees157
Security typeOrdinary Share
Fiscal year-endJul 20
Address6455 Nancy Ridge Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18584500008
Websitehttps://www.cibus.com/
Ticker SymbolCBUS
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)

Company Executives of Cibus Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Co-Founder, Director
Co-Founder, Director
14.96M
--
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Co-Founder, Director
Co-Founder, Director
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Chief Executive Officer
Chief Executive Officer
894.31K
--
Mr. Craig Wichner
Mr. Craig Wichner
Chief Executive Officer
Chief Executive Officer
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Co-Founder, Chief Operating Officer
President, Co-Founder, Chief Operating Officer
592.70K
+38.19%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Co-Founder, Chief Operating Officer
President, Co-Founder, Chief Operating Officer
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Co-Founder, Director
Co-Founder, Director
14.96M
--
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Co-Founder, Director
Co-Founder, Director
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Chief Executive Officer
Chief Executive Officer
894.31K
--
Mr. Craig Wichner
Mr. Craig Wichner
Chief Executive Officer
Chief Executive Officer
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Co-Founder, Chief Operating Officer
President, Co-Founder, Chief Operating Officer
592.70K
+38.19%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Co-Founder, Chief Operating Officer
President, Co-Founder, Chief Operating Officer
592.70K
+38.19%

FAQs

Who are the top five shareholders of Cibus Inc?

The top five shareholders of Cibus Inc are: Mr. Rory B. Riggs

How many institutions hold shares of Cibus Inc (CBUS)?

As of 2026Q1, 162 institutions hold shares of Cibus Inc, with a combined market value of approximately 12.20M, accounting for 16.60% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2351528.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.